Clinical trial
Phase I Study in Patients With Solid Tumours
NCT00496028 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00496028 |
|---|---|
| Title | Phase I Study in Patients With Solid Tumours |
| Official title | A Phase I, Open-label Study to Assess the Safety and Tolerability of AZD0530 in Combination With Carboplatin and/or Paclitaxel Chemotherapy in Patients With Solid Tumours |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | AZD0530, Carboplatin, Paclitaxel |
| Enrollment | 148 |
| Start date | Mar 1, 2007 |
| Primary completion | Jan 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Jul 4, 2007 |
| Last update posted | Sep 22, 2010 |
| Countries | France, Netherlands, Norway, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: